Xolair is an injectable drug indicated in adults and children with moderate to severe persistent allergic asthma, whose symptoms are not controlled with inhaled corticosteroids.
The active ingredient of this remedy is omalizumab, a substance that decreases levels of free IgE antibodies in the body, responsible for triggering the allergic cascade, thus decreasing the incidence of asthma exacerbations.
- Xolair is indicated in adults and children over 6 years of age with moderate to severe persistent allergic asthma that cannot be controlled with inhaled corticosteroids.
Learn how to identify asthma symptoms in infants, children, and adults.
The doctor should determine the dose of Xolair and the frequency of administration, depending on the serum level of reference immunoglobulin E, to be measured prior to initiation of treatment, depending on body weight.
Xolair is counterinsitive in cases of hypersensitivity to the active substance or one of the components of the formula and in children under 6 years of age.
In addition, this medicine should not be used in pregnant or nursing women without medical advice.
Some of the side effects that may occur during treatment with Xolair are headaches, pain in the upper abdomen and injection site reactions, such as pain, erythema, itching and swelling.
In addition, although it is rarer, pharyngitis, dizziness, drowsiness, paresthesia, fainting, orthostatic hypotension, redness, cough, allergic bronchospasm, nausea, diarrhea, poor digestion, hives, photosensitivity, weight gain, fatigue, swelling of the arms and flu symptoms..
Watch the video below as well, and find out how food can help reduce asthma attacks: